Introduction
Over the past 30 years, allogeneic hematopoietic stem cell transplantation (SCT) has emerged as a curative therapy for a number of lethal disorders affecting the hematopoietic system [1] [2] [3] [4] [5] .
After conditioning with high doses of chemo-radiotherapy, pancytopenia occurs and infectious complications, including bacterial bacteremia, invasive fungal infections and viral infections, are common [6] [7] [8] [9] . During the pancytopenic phase, the patients are kept in a protected environment, such as laminar air flow rooms (LAF) or reversed isolation [10] [11] [12] [13] . Despite this, infectious complications are common causes of morbidity and mortality shortly after SCT.
Home care is mainly used for palliative care in end-stage cancer patients and in geriatrics 14, 15 .
However, there is some controversy regarding the quality of life and costs as compared to hospital care [16] [17] [18] [19] . In more recent years, home care for outpatients has been given in some centers performing autologous stem cell transplantation 15 . One study of SCT allowed patients to leave their rooms and the hospital at will 20 . Patients living close to the hospital were allowed to go home for a few hours and sometimes overnight. We used another approach in our SCT patients. After conditioning and transplantation in the hospital, the patients were given the opportunity to be treated at home during the pancytopenic phase. An experienced nurse from our unit visited the patients once or twice daily until the patient could be discharged to the outpatient clinic. To our knowledge, this has not been done before. A pilot study including 11 patients treated at home in this way, showed that the procedure was safe 21 .
In the present study, we planned to treat 36 patients at home during the pancytopenic phase, two of them could not go home for medical reasons. We compared these 36 patients to 18
patients who were offered home care, but preferred hospital care. Since some of these patients might have been less psychologically fit than those treated at home, we also compared a
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4 (34) second control group of 36 patients, matched for various risk-factors, to the home care group.
They came from other parts of Sweden, or abroad, where home care was not possible, because they lived too far from the hospital. The aim of the study was to compare outcome of home care to hospital care after SCT.
Material and Methods

Patients and patient selection for home care
From 1 March 1998, until 31 December 2000, 179 patients underwent ASCT at Huddinge University Hospital and of those 60 lived in the Stockholm area. All patients living within one hour's driving distance from Huddinge University Hospital undergoing SCT and judged eligible by our medical team were offered home care from the day of transplantation. Six of the sixty patients living in the Stockholm area were not asked because they didn't speak Swedish (2) , were addicted to narcotics (2) or were considered medically and psychologically unfit (2) . Of the 54 patients who were asked, 36 preferred to stay at home and fulfilled the requirements: 1) a caregiver, relative or friend, willing to stay at home and help; 2) approval of the home by the Head of the Department of Infection Control. The department required:
water-temperature >50 o C to prevent the spread by tap water of legionnaires' disease, no flowers in pots because the earth may contain Aspergillus, no pet animals at home, sheets changed three times a week and the home cleaned once a week. These criteria could not be fulfilled by 18 who had no caregiver (15) , had pets in the home (2) or would not feel safe at home (1) and they served as control group 1. None of these patients were excluded because of their clinical condition. To avoid the bias that more fitter and determined patients chose to stay at home than those treated in the hospital, we also selected a control group of patients not eligible for the study, because they resided outside the Stockholm area and matched them for as many variables as possible including diagnosis, stage of disease, age, gender, type of donor were included in the study (plus two who were retransplants), 30 patients had hematological malignancies, but could not be well matched for prognostic variables with the home care patients, 46 were children <18 years of age, 20 had solid tumors, two had aplastic anemia, one had a metabolic disorder, four received "minitransplants" and one received an HLA mismatched graft. Two patients in the home care group could not go home after the transplantation as planned, because they were in too poor clinical condition. One had retinitis and was almost blind and the other was admitted to the ICU because of respiratory insufficiency and multiorgan failure. Both patients were included in the home care group so as not to introduce a bias and because we wished to treat them at home. The study group and the controls were well matched for diagnosis, disease status, gender, age, type and age of donor, source of stem cells, G-CSF treatment after the transplantation and conditioning (Table 1) .
Control group 2 showed a trend for a lower median dose of nucleated cells than the study group (p<0.06).
Information
All patients and their caregivers, a relative or friend, were informed about the procedure before they chose home care or hospital care. Conditioning was given in the hospital when the patient and caregiver received information and education about the procedure by the staff, social workers, dietician and physical therapist. The caregiver stayed together with the patient in the hospital during this time to learn about the procedure and to know the staff. The most important thing for the caregiver at home was to be company for the patient, to make food if (34) needed and to give a call to the hospital if help was necessary. We wished to give the patient an opportunity to stay at home as much as possible if he/she wanted to. They were always welcome back to the hospital if they or the caregiver preferred it. We did not have an empty bed waiting for the patients at home, but we had planned in advance which room could be used in case a home care patient came to the hospital.
Conditioning
Conditioning consisted of cyclophosphamide (Cy) 60 mg/kg for two days, combined with 10 Gy of total body irradiation (TBI), single fraction, with the lungs shielded to receive no more than 9 Gy, or fractionated 3 Gy daily for four days 22 . The amount of Busulfan (Bu) 4 mg/kg/day, divided into four doses given for four days (total dose 16 mg/kg), was adjusted to the Bu levels 23, 24 . It was combined with Cy 60 mg/kg for two days. A few patients were given reduced conditioning including fludarabine 30 mg/m 2 /day for six days, combined with Bu 4 mg/kg/day for two days (total dose 8 mg/kg), combined with thymoglobulin (Sangstat, IMTIX, Lyons, France) 2 mg/kg/day for four days 25 . In patients who received unrelated grafts, thymoglobulin 2 mg/kg/day was given for two to four days before SCT 22, 26 . (34) are performed twice weekly for the first three months and thereafter less frequently, dependent on the status of the patient. When patients are readmitted to the hospital, adults are cared for at CAST and children at the Department of Pediatrics.
Centre infrastructure and outpatient management
Home care
After the graft had been infused, the patients could go home. An experienced nurse from the ward visited the patient once or twice daily, for a median of 1 hours, range 0.5 to 3 hours, depending on the needs from the patient. She checked vital signs, including temperature and blood pressure, and examined the patient's mouth for mucositis, herpes lesions and fungi, as well as the skin for acute GVHD or other lesions. In the morning, she took blood samples from the central venous line (10-25 ml/day) and gave i.v. medications, erythrocyte transfusions if the patient had a Hb <80 g/l, and platelet transfusions when the platelet count fell below 30 x 10 9 /l, or if there were signs of hemorrhage [21] [22] [23] 26 . If the patient's fluid intake was less than 2 l/24 hours and weight had decreased by more than 2 kg, parenteral nutrition was started. If the patient could not feed himself at all, total parenteral nutrition (TPN) was given. Mucosal pain was treated with oral paracetamol or oral morphin. If this was not sufficient, continuous i.v. morphin was given, using a home pump. If the nurse needed any advice, she called the physician at the ward when she visited the patient. At the hospital, the nurse and the physician went through all the clinical and laboratory data. After this, the physician called the patient to tell about the chemistry results, to check the patient's status and to change medications, if needed. The patient was asked to take his temperature frequently and if it rose above 38.5 o C, he/she was to call the unit and return to the hospital. This was done to ensure that they did not develop septic shock or acute respiratory distress syndrome at home. Blood cultures and a chest x-ray were taken at the SCT unit and i.v. antibiotics were started. After a check-up in the hospital for an infection and, if the patient felt well, he could (34) go home even with a fever; i.v. antibiotics were continued at home. Criteria for admission to the ward were 1) if the patient was deteriorating, 2) the first time temperature rose above 38.5 o C, 3) if the patient needed i.v. injections more than twice daily, 4) if the caregiver was unable to stay at home and support the patient. Before admission to the ward, the patient or the caregiver always contacted the responsible physician.
Hospital care
These patients were treated in conventional single rooms with reversed isolation and a relative or friend could stay with them 22 . They could take a walk outside the hospital after 6:00 p.m.
on weekdays and during weekends 21, 22, 26 . Patients treated in the hospital and at home were asked to avoid persons with symptoms of or having contagious diseases, going near construction areas when they were out walking due to the risk of aspergillosis, visiting anyone and Subsequent blood cultures were obtained when patients had a high fever and chills or in the event of a continuous fever, two to three times weekly.
Immunosuppression and donors
Cyclosporine (CyA) combined with four doses of methotrexate was given as prophylaxis against graft-versus-host disease (GVHD) 22, 23, 26, 27 . One patient in the home care group with a twin donor received no prophylaxis. Only a few patients were given CyA and prednisolone (Table 1) . Of the donors in the home care group, one was an identical twin, ten were HLAidentical siblings and 25 HLA-A, -B and -DR 1 compatible unrelated. HLA matching criteria were the same in the home care and the hospital care patients. In control group 1, seven were HLA-identical siblings and eleven unrelated donors. In control group 2, twelve were HLAidentical siblings and 24 unrelated donors. Details regarding treatment have been reported elsewhere in detail 22, 23, 26 .
Monitoring
Patients at home were monitored using the same charts and chemistry as patients in the hospital. Patient therapy compliance was noted in the charts. serology, fever, bacteremia, acute GVHD (grades 0-I vs. II-IV), time to engraftment, absolute neutrophil count (ANC >0.5 x 10 9 /l), nucleated cell dose, donor age, donor gender and female donor to male recipient. Home care was the main factor to be tested while all the other factors were included to control for differences between the groups. To correct for multiple comparisons a Bonferroni correction was made. As 5 multivariate analysis were made, the new significance level will be 0.05/5=0.01. Only patients surviving more than 30 days were included in the analysis of acute GVHD. A minimum of 90 days of follow-up was a criterion for relapse and chronic GVHD.
Calculation of costs
The costs were calculated from the day of transplant. It did not include costs prior to transplant, such as tissue typing, donor search, cell harvest, etc.The costs, calculated as US$ 1,084/day in the hospital, included medication, hospital bed and staff. The same costs were calculated for patients staying at home, because the ward also served as a back-up for the (34) home care patients. The costs were calculated until day 76, i.e., the last day of discharge from the hospital among the control patients (Table 2) . Every visit to the outpatient clinic was estimated at US$ 200. The cost/day when the patients were readmitted to the ward was US$ 798. This calculation does not include loss of income to patients and caregivers. This is covered by the health insurance system in Sweden. Patients in the hospital could also have a relative and a friend staying with them. The health care system in Sweden pays for a relative for 60 days as a caregiver.
Results
Days at home in the home care group
Among the 36 patients in the home care group, two never went home, because they were too sick to leave the hospital. The others went home on median day +1 after the transplantation (range 0-8). One patient had to wait until day 8, because she had no caregiver at home until then. Twenty-one of the 34 patients were readmitted to the ward on 33 occasions, median 1 (0-25) days, because of fever (n=24), no caregiver at home (2), diarrhea ± fever ± pain (3), pain (1), GVHD (1), nausea and vomiting (1) and mucositis (1).
The time to discharge to the outpatient clinic was significantly faster in the home care group than in the control groups -i.e., median 19 days versus 29 days (Table 3 , p<0.01). In the univariate analysis, a short time to discharge was associated with home care, fast engraftment, no CMV infection and no bacteremia ( Table 4 , Fig. 1 ). In the multivariate analysis, fast engraftment, home care and no CMV reactivation were associated with a short time to discharge (Table 5 ).
For
Fever and infections
We found no difference between the days with fever 38.5 o C in the home care group and the controls (Table 3) , but, significantly more blood cultures were taken in the two control groups than in the home care group (p=0.01). Bacteremia occurred in 25% of patients in the home care group versus 44% and 39% in the two control groups, respectively (Table 3, ns). In the multivariate analysis, bacteremia was associated with a male recipient (p<0.05). The days on i.v. antibiotics was the same in the three groups (Table 3) .
Engraftment and transfusions
Engraftment, time to WBC >0.2 x 10 9 /l, time to ANC >0.5 x 10 9 /l and time to platelets >30 x 10 9 /l were similar in the home care group and the control groups (Table 3 , Fig. 1a ). Likewise, we found no difference in number of platelet transfusions in the home care group and the controls. However, control group 1 needed significantly more erythrocyte transfusions (median 7 versus 4) than the home care group (Table 3 , p<0.05).
Analgesics and TPN
A median of 1 day on analgesics in the home care group was significantly lower than a median of 15 in control group 1 (Table 3 , p<0.05). In the multivariate analysis, i.v. analgesics
were associated with CMV seropositivity in the recipient and/or donor (Table 5) . A median of four days on TPN in the home care group was significantly shorter than 23 and 10 days in the control groups, respectively (Table 3 , p<0.001, p<0.01). In the univariate analysis, days on TPN was associated with hospital care, delayed engraftment, CMV reactivation and bacteremia (Table 4 ). In the multivariate analysis, TPN was associated with hospital care and delayed engraftment (Table 5 ).
GVHD and TRM
The probability of grades II-IV acute GVHD in the home care group was 17%, which was significantly lower than 42% and 45% in the controls, respectively (Fig. 2, p<0.05 ). In the univariate and multivariate analyses, acute GVHD grades II-IV was associated with hospital care and PBSC, as compared to BM as the cell source (Tables 4,5 ). TRM was 8% in the home care group, which was significantly better than in the control groups -i.e., 49% and 35%, respectively (Fig. 3, p<0 .01, p=0.02). In the univariate and multivariate analysis, TRM was associated with acute GVHD, hospital care and bacteremia (Table 4, 5).
Reasons for death and survival
The reasons for death in the three groups are listed in Table 6 . The two-year survival rate was 70% in the home care group (<0.03), compared to 51% and 57% in control groups 1 and 2 (Fig. 4) . In the univariate analysis, death was associated with acute GVHD grades II-IV, bacteremia and hospital care (Table 3 ). In the multivariate analysis, death was associated with GVHD and bacteremia (Table 4) .
Bonferroni correction
After correction for multiple analysis (Bonferroni correction), home care was statistically associated with fewer days on TPN (p<0.01) and a lower incidence of acute GVHD grades II-IV (p=0.01)( Table 5 ).
Quality of life
All patients and their caregivers answered an anonymous questionnaire when they were discharged to the outpatient clinic. No patient treated at home regretted this decision. They were glad to stay with their family and to take part in activities at home and walk when they 
Costs
The median costs of treatment from day 0 until day +76 were US$ 25,340 for the home care group, compared to US$ 36,437 for control group 1 (p<0.001) and US$ 33,620 for control group 2 (p<0.05, Table 2 ). In the multivariate analyses, high costs were associated with late engraftment, acute GVHD grades II-IV and hospital care ( Table 5) .
Discussion
This study of home care of SCT patients during the pancytopenic phase using experienced nurses from the Stem Cell Transplant Ward was supported by a grant from the Swedish Cancer Society for three years. The main reason for the project when it started was to allow the patient to be treated at home instead of in a hospital. The first aim was to find out whether it was safe and useful for the patients and their relatives. The trial was not randomized because we wished to treat as many patients as possible at home during this period. Many people opposed this because they thought the patients might die at home. Therefore, the pediatricians initially refused to have children participate in it only adults were included. To reduce the risk of sudden death at home -e.g., from septic shock, or the adult respiratory (34) distress syndrome -the patients were taken to the hospital when they had a fever >38.5 o C.
Many of them (62%) were readmitted to the unit. However, after a median of 1 day in the hospital, they could go home again and and stay there.
The first patients and their caregivers were very enthusiastic and, after 17 months, 11 patients had been treated at home. We then did a safety evaluation of the study 21 . At that time, 22
patients had been given the choice of being treated at home. Eleven could not be treated at home, and they served as controls. In this evaluation, we found to our surprise that the patients treated at home had bacteremia less often, fewer days on TPN, fewer erythrocyte transfusions, fewer days on i.v. antibiotics and i.v. analgesics than the controls. This preliminary study indicated not only that it was safe to be treated at home during the neutropenic phase after SCT, but better in many respects than isolation in the hospital.
As the study continued, more patients wanted to be treated at home and two children, 14 and 15 years of age, were included. Although 36 patients had agreed to be treated at home, 18
were not because they had no caregiver, felt safer in the hospital, etc. We were criticized for selecting controls who were eligible for the home care project, but could not take part in it.
This could have introduced a bias in which the controls treated in hospital were more or less psychologically fit and had a worse outcome than those treated at home. To overcome this problem, we added another control group consisting of 36 patients who could not be offered treatment at home, because they lived too far away from the Stockholm area. These controls were matched for as many prognostic variables as possible (Table 1) . On the whole, they are typical of those who have undergone a transplantation in our unit during the past few years.
For instance, we use more unrelated donors than HLA-identical siblings and PBSC more frequently than BM 26, 30 .
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16 (34) The home care group had several advantages compared to the two control groups. They could be discharged to the outpatient clinic faster although the times to engraftment of ANC and platelets were the same (Table 3 ). Since they usually took care of their food and medication themselves, they could be discharged to the outpatient clinic earlier than those treated in hospital who more often had trouble in eating. Other reasons for an earlier discharge may be that the home care patients could eat and drink more and therefore required less TPN than the controls treated in the hospital, were more active and therefore had a better appetite. They could also go to their own kitchen and take something they were used to and liked to eat whenever they wanted. They probably felt more like eating because they could eat their meals together with their family. The larger space and the walks outside may also have stimulated the appetite. They also may have forced themselves to eat because of the wish to stay at home.
We also found that the home care patients were less likely to develop grades II-IV acute GVHD than the controls (Fig. 2, Tables 4, 5) . The reasons for this may have been better nutrition and maybe a trend for less bacteremia. Infections can lead to GVHD. For instance, gnotobiotic mice have a lower risk of developing GVHD 31, 32 . A clinical study showed that patients treated in laminar air flow rooms were less likely to develop GVHD than those treated in regular hospital rooms 33 . Because of the lower risk of GVHD in the home care group, TRM was also significantly lower in this group than in the controls (Fig. 3 , Tables 4,   5 ).
In the safety analysis of this study, the main concern was the risk of septic shock or the adult respiratory distress syndrome, which are fatal complications. However, none of the patients in the three groups died of these conditions. Another concern was whether the risk of an (34) Aspergillus infection would increase in the home care group, who were not isolated.
However, so far, no patient has acquired a clinical Aspergillus infection. Indeed, such infections were rare in our SCT patients 7 . This may be due to our cool climate, since other studies have reported reduced Aspergillus infection rates in SCT patients who are strictly isolated 12, 34 .
In the analysis of TRM and survival, the disease and stage of the disease were not significant in comparison to GVHD, bacteremia and hospital care. One reason for this may have been the short follow-up because only a few patients so far have had a relapse of their hematologic malignancy (Table 6 ). Relapse is otherwise a major cause of mortality after SCT for hematological malignancies [1] [2] [3] [4] [5] .
It is obvious that most patients who were given the opportunity to be treated at home appreciated this option. Unfortunately, this could only be offered to those living close to the hospital and a specialized SCT unit. Indeed, no patient regretted this decision. As regards the quality of life, we could not compare the groups, because most of those treated in the hospital were not eligible for treatment at home.
As regards costs, it was cheaper at home because these patients were discharged earlier to the outpatient clinic (Tables 2, 3, 4) . Home care is probably also cheaper than hospital care because they required less TPN and antibiotics and, in addition, TRM was reduced and more lives were saved. Furthermore, fewer nurses and doctors were needed and the hospital beds could be used more efficiently. Home care can function only if experienced nurses from an SCT unit and hospital beds are available when needed in case of an emergency or high fever.
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Then, home care can be used to supplement hospital care for patients living near specialized SCT units.
There are several differences favouring the home care arm. With the Bonferroni correction, it cannot be excluded that the lower TRM, may be influenzed by chance. Still, the study provide evidence that patients are not put at risk by being treated at home.
To conclude, home care during the pancytopenic phase after SCT is a novel and safe approach. According to this study, it had several advantages, such as faster discharge, reduced need for TPN, a lower incidence of acute GVHD, lower TRM and costs than patients treated in the hospital. This study should be used as the basis for a prospective randomized study comparing home care with hospital care after SCT. Fig. 1. a) Time to and cumulative incidence of absolute neutrophil count (ANC) >0.5 x 10 9 /l in patients treated at home ( ) (ns) and in control groups 1 (--------) and 2 (………).
Legends to figures
N=number of patients in each group.
b) Time to and cumulative incidence of discharge to the outpatient clinic in patients treated at home ( ) (p<0.01) or in control groups 1 (--------) and 2 (………). Time to and cumulative incidence of acute graft-versus-host disease (GVHD) grades II-IV in home care patients ( ) (p<0.05) and control groups 1 (--------) and 2 (………). For personal use only. on April 15, 2017 . by guest www.bloodjournal.org From
